CLU and pancreatic neoplasm: A recent study on the molecular mechanism of BRCA mutations and CAF in pancreatic cancer reported enhancement of clusterin in BRCA1 or BRCA2 mutant CAF in a heat shock factor 1-dependent manner [46].